Evidence map›Paper›PMID 32561689›Full record

ArticleAging2020

Comparison of prognostic prediction models for rectal gastrointestinal stromal tumor.

Liu Jiaxin, Zhou Peiyun, Tang Zheng, Yuan Wei, Shen Shanshan, Ren Lei, Xing Zhengwen, Fang Yong, Gao Xiaodong, Xue Anwei and 2 more

Open access · greenAbstract readComparative StudyValidation Study
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Comparing endoscopic ultrasonography and double contrast-enhanced ultrasonography in the preoperative diagnosis of gastric stromal tumor.Cancer imaging : the official publication of the International Cancer Imaging Society · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Liu JiaxinDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhou PeiyunDepartment of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, China.
Tang ZhengDepartment of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, China.
Yuan WeiDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Shen ShanshanDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Ren LeiDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Xing ZhengwenDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Fang YongDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Gao XiaodongDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Xue AnweiDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Shen KuntangDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Hou YingyongDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Fudan University · CNSun Yat-sen University · CNThe First Affiliated Hospital, Sun Yat-sen University · CNZhongshan Hospital · CNShanghai Chest Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRectal gastrointestinal stromal tumors (RGISTs) are biologically characterized tumors that are relatively rare. Thus, few studies have reported a specific prognostic system for this subset of tumors but integrated it into parallel systems, such as small intestine. Our aim is to develop a new predictive staging system nomogram (named FD-ZS system) for RGISTs.

resultsTumor size and mitotic rate were independent risk factors for tumor recurrence in RGISTs according to univariate and multivariate survival analyses. A prognostic predictive nomogram was developed, and a cut-off value of 65 points was calculated by X-tile to discriminate risk based on tumor size and mitotic rate. The C-indices for the FD-ZS, FD-Hou, NIH, and WHO systems were 0.706, 0.693, 0.687, and 0.680, respectively.

conclusionIn the present study, a concise two-tier grading system (FD-ZS) for prognostic prediction of RGISTs that is simpler to several reported systems was developed, and a cut-off value was established to help RGIST patients determine whether to undergo adjuvant imatinib treatment.

methodsA nomogram was employed, and its predictive accuracy and discriminative ability were determined by concordance index (C-index) and calibration curve analyses. The nomogram was then compared with three stratification systems used for GISTs (FD-Hou, NIH, and WHO).

Indexed as

NomogramsProctectomyAdultAgedChemotherapy, AdjuvantClinical Decision-MakingDisease-Free SurvivalFemaleFollow-Up StudiesGastrointestinal Stromal TumorsHumansImatinib MesylateIntestinal MucosaMaleMiddle AgedNeoadjuvant TherapyImatinib Mesylatenomogramrectal GISTstratification

Identifiers

PMID32561689
PMCPMC7343501
OpenAlexW3035830457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.